HomeXTLB • NASDAQ
add
X T L Biopharmaceuticals Ltd
Previous close
$1.82
Year range
$0.77 - $4.99
Market cap
22.98M USD
Avg Volume
15.74K
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 46.00K | — |
Operating expense | 810.00K | 436.42% |
Net income | -553.00K | -157.21% |
Net profit margin | -1.20K | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.72M | -22.03% |
Total assets | 9.28M | 248.48% |
Total liabilities | 3.56M | 2,099.38% |
Total equity | 5.72M | — |
Shares outstanding | 881.39M | — |
Price to book | 182.00 | — |
Return on assets | -32.71% | — |
Return on capital | -48.05% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -553.00K | -157.21% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1993
Headquarters
Website
